Rina Aharoni
Herzel St 1
Rehovot, M 76100, Israel
Rehovot, M 76100, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
GPR37 modulates remyelination following demyelinating injury.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: February 18, 2026
Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair.
Journal: Pharmacological reviews
Published: January 31, 2024
Repurposing of glatiramer acetate to treat cardiac ischemia in rodent models.
Journal: Nature cardiovascular research
Published: September 21, 2023
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis.
Journal: Frontiers in chemistry
Published: February 27, 2022
Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: November 03, 2021
Astrocytes in Multiple Sclerosis-Essential Constituents with Diverse Multifaceted Functions.
Journal: International journal of molecular sciences
Published: May 10, 2021
Titration of myelin oligodendrocyte glycoprotein (MOG) - Induced experimental autoimmune encephalomyelitis (EAE) model.
Journal: Journal of neuroscience methods
Published: September 07, 2020
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
Journal: Nature communications
Published: April 17, 2020
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
Journal: Journal of neuroimmunology
Published: April 08, 2020
Corrigendum to "Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis" [J Neuroimmunol. 2019 Dec 15;337:577070. doi: 10.1016/j.jneuroim.2019.577070. Epub 2019 Oct 24].
Journal: Journal of neuroimmunology
Published: January 01, 2020
Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis.
Journal: Journal of neuroimmunology
Published: April 02, 2019
Glatiramer Acetate: from Bench to Bed and Back.
Journal: The Israel Medical Association journal : IMAJ
Published: March 25, 2019
Last Updated: 09/26/2026